Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Organic Letters|April 2, 2002
p-Methoxybenzyl ether cleavage by polymer-supported sulfonamidesRonald J Hinklin, Laura L KiesslingOrganic Letters|November 19, 2004
Stereoselective N-glycosylation by Staudinger ligationYi He, Ronald J Hinklin, Jiyoung Chang, et al.Organic Letters|December 8, 2022
A Decarboxylative Cross-Coupling Platform To Access 2-Heteroaryl Azetidines: Building Blocks with Application in Medicinal ChemistryJames T Brewster, Samuel D Randall, John Kowalski, et al.Organic Letters|April 4, 2025
Alkyl Azetidines Via Batch and Flow PhotochemistryOleksandr P Datsenko, Andrii Baziievskyi, Iryna Sadkova, et al.Journal of Medicinal Chemistry|September 11, 2013
Identification of a new class of glucokinase activators through structure-based designRonald J Hinklin, Steven A Boyd, Mark J Chicarelli, et al.Journal of Medicinal Chemistry|September 10, 2014
Discovery of 2-pyridylureas as glucokinase activatorsRonald J Hinklin, Thomas D Aicher, Deborah A Anderson, et al.ACS Medicinal Chemistry Letters|July 21, 2016
5-Alkyl-2-urea-Substituted Pyridines: Identification of Efficacious Glucokinase Activators with Improved PropertiesTodd J Kohn, Xiaohui Du, SuJen Lai, et al.Bioorganic & Medicinal Chemistry|December 11, 2019
Discovery and preclinical development of AR453588 as an anti-diabetic glucokinase activatorRonald J Hinklin, Brian R Baer, Steven A Boyd, et al.ACS Medicinal Chemistry Letters|July 21, 2016
Novel Series of Potent Glucokinase Activators Leading to the Discovery of AM-2394Paul J Dransfield, Vatee Pattaropong, Sujen Lai, et al.ACS Medicinal Chemistry Letters|December 20, 2023
Discovery of 5-Azaquinoxaline Derivatives as Potent and Orally Bioavailable Allosteric SHP2 InhibitorsMohamed S A Elsayed, James F Blake, Mark L Boys, et al.Pageof 2